Pharmaceuticals & Biotechnology | Pharma & Biotech Resources
Summary: Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community Through Pharma IQ, you will be able to access pharmaceutical information resources such as
- Visit Website
- RSS
- Artist: Unknown
Podcasts:
As part of our Future Pharma series, Pharma IQ is examining the promise held by synthetic biology. Our editor spoke to Professor James Collins, Professor of Biomedical Engineering at Boston University and founding faculty member at the Weiss Institute at Harvard University . Professor
Jürgen Blusch, Head of Cell Substrate Analytics at Novartis speaks to Pharma IQ on the topics of mitigating risk in pathogen safety, new technologies and techniques such as nucleic acid based techniques for safety testing. He also spoke about what is limiting the uptake of these
Jürgen Blusch, Head of Cell Substrate Analytics at Novartis speaks to Pharma IQ on the topics of mitigating risk in pathogen safety, new technologies and techniques such as nucleic acid based techniques for safety testing. He also spoke about what is limiting the uptake of these
Effective management of compound libraries remains crucial for drug innovation and discovery. In this podcast Timothy Dunne, Scientist, Pfizer, speaks to Andrea Charles from Pharma IQ, about the main reasons for sample integrity being compromised and how Pfizer seek to attain the highest
Effective management of compound libraries remains crucial for drug innovation and discovery. In this podcast Timothy Dunne, Scientist, Pfizer, speaks to Andrea Charles from Pharma IQ, about the main reasons for sample integrity being compromised and how Pfizer seek to attain the highest
Rob Dekkers' current role is Logistics and Distribution Leader - EMEA Working for GE Healthcare. He faces perhaps what could be described as the ultimate distribution challenge: radiopharmaceuticals. Facing a ticking clock, a temperature sensitive cargo and strict regulations,
Rob Dekkers' current role is Logistics and Distribution Leader - EMEA Working for GE Healthcare. He faces perhaps what could be described as the ultimate distribution challenge: radiopharmaceuticals. Facing a ticking clock, a temperature sensitive cargo and strict regulations,
In this interview hosted by John Trigg Director, director, phaseFour Informatics , Roman Affentranger, Ph.D., External Consultant, F. Hoffmann-La Roche AG, Pharma Research & Early Development Informatics explains the scope of Roche's ELN and
Starting with a clean sheet. Allan Jordan, Head of Chemistry at the Paterson Institute for Cancer Research, shares his experiences of building a bespoke ELN with Andrea Charles from Pharma IQ. Jordan reveals the perils and pitfalls of creating an ELN for the academic environment and some
In this interview hosted by John Trigg Director, director, phaseFour Informatics , Roman Affentranger, Ph.D., External Consultant, F. Hoffmann-La Roche AG, Pharma Research & Early Development Informatics explains the scope of Roche's ELN and
Starting with a clean sheet. Allan Jordan, Head of Chemistry at the Paterson Institute for Cancer Research, shares his experiences of building a bespoke ELN with Andrea Charles from Pharma IQ. Jordan reveals the perils and pitfalls of creating an ELN for the academic environment and some
Peter Staller Director of Oncology Research at Epitherapeutics talks to Pharma IQ about the differences between traditional drug development techniques and those required for development of a epigenetic therapy. He also discusses epigenetics as a growing area for finding druggable
Peter Staller Director of Oncology Research at Epitherapeutics talks to Pharma IQ about the differences between traditional drug development techniques and those required for development of a epigenetic therapy. He also discusses epigenetics as a growing area for finding druggable
" Setting data free. We cannot predict how or why data will be used in the future " - Morten Meldgaard, Project Director, Chr. Hansen. In this exclusive Pharma IQ podcast John Trigg, Director, phaseFour Informatics a nd Morten Meldgaard, Project Director, Chr. Hansen A/S,
" Setting data free. We cannot predict how or why data will be used in the future " - Morten Meldgaard, Project Director, Chr. Hansen. In this exclusive Pharma IQ podcast John Trigg, Director, phaseFour Informatics a nd Morten Meldgaard, Project Director, Chr. Hansen A/S,
